Why Ambiguous Definitions Need Planned Alternatives
A target-trial protocol can be clear in principle while its operational translation to records remains uncertain. A diagnosis may be supported by one code or require two; treatment initiation may be identified from a dispensing record or an administration record; an outcome may include only hospitalizations or a broader set of acute-care events; and follow-up may end at a fixed day or at a different prespecified horizon. Each choice can change who enters the emulation, how treatment strategies are assigned, which events count, or how long outcomes are observed.
A protocol sensitivity analysis makes these choices visible before comparing results. It specifies a defensible primary definition and alternative operational definitions, then evaluates what changes when those alternatives are applied. The exercise is not a search for the version with the preferred result. Nor does stability across definitions prove that the causal assumptions hold. It assesses sensitivity to a particular source of operational uncertainty.
The key distinction is between a rule that is uncertain because records support more than one credible interpretation and a rule changed after seeing which result is more favorable. Sensitivity alternatives should be justified by clinical meaning, data provenance, or plausible measurement practice—not by their effect estimate.
Specify the Ambiguity and Its Consequences
For each uncertain definition, document the source of ambiguity, the primary rule, the alternative rule or rules, and the data needed to implement them. Also state whether the alternative changes the target population, treatment-strategy classification, outcome variable, follow-up horizon, or more than one of these. Varying one dimension at a time makes the consequence easier to interpret; joint alternatives can then examine plausible combinations when the uncertainties may interact.
| Protocol element | Example of an operational ambiguity | Possible consequence |
|---|---|---|
| Eligibility | One diagnosis record versus two records on separate dates | Changes who is eligible and potentially the target population |
| Exposure | Dispensing record only versus dispensing or documented administration | Changes treatment classification and the contrast represented |
| Outcome | Hospitalization only versus hospitalization or emergency care | Changes the outcome being measured |
| Follow-up | Outcome through day 30 versus through day 90 | Changes the time horizon of the outcome |
An alternative is informative only if the data can implement it with reasonable fidelity. If records do not distinguish administrations from dispensings, an “administration-only” scenario may be impossible, not merely inconvenient. Feasibility should be assessed before the alternatives are finalized. Likewise, every scenario must preserve a coherent time origin and treatment assignment rule; otherwise the comparison can silently introduce a different design problem rather than test the stated ambiguity.
Why Definition Changes Can Change the Estimand
Let \(E\) denote eligibility under a specified rule, \(A\) the treatment strategy, and \(Y^a(\tau)\) the outcome by follow-up horizon \(\tau\) that would be observed under strategy \(a\). For a binary outcome, one possible causal contrast is the risk difference in the eligible population:
This notation makes two points explicit. First, changing the eligibility rule changes the conditioning population and can therefore change the target estimand. Second, changing the outcome definition or the follow-up horizon changes \(Y^a(\tau)\) itself. A change in an estimate is not automatically evidence that the analysis is unreliable: the alternative may be asking a different causal question.
For example, suppose a stricter eligibility rule selects a subset of a broader eligible population. The broader risk under strategy \(a\) can be written as a weighted average of the risk in that subset and the risk among those excluded by the stricter rule:
where \(w=P(E_{\text{strict}}=1\mid E_{\text{broad}}=1)\), provided strict eligibility is nested within broad eligibility. The equation follows by partitioning the broad eligible group into those meeting the strict rule and those not meeting it, then applying the law of total probability. Unless the two groups have the same outcome risk under each strategy, the broad and strict risks—and potentially their contrast—can differ. This is a population change, not necessarily an estimation error.
A causal interpretation of any estimate still requires the assumptions appropriate to the design and analysis, including valid treatment assignment, adequate control of confounding where needed, consistency, and sufficient support. Comparing operational definitions does not establish these assumptions. It asks a narrower question: what does this emulation produce under alternative defensible translations of the protocol into data?
Worked Example: A Stricter Eligibility Rule Changes the Population
Hypothetical data. Consider an emulation with a broad eligibility rule based on one diagnosis record. A stricter alternative requires confirmation, and the strictly eligible group is a subset of the broad group. In the broad group, 500 people are classified in each treatment strategy: 40 treated-strategy participants and 60 comparison-strategy participants have the outcome. Within the strict group, there are 400 people per strategy, with 36 and 32 outcomes, respectively. Calculate the crude observed risk difference in each population, defined as treated-strategy risk minus comparison-strategy risk.
Under broad eligibility, the observed risks are \(40/500=0.0800\) and \(60/500=0.1200\). Thus:
The crude observed risk difference is \(-4.00\) percentage points in the broad group. Under strict eligibility, the risks are \(36/400=0.0900\) and \(32/400=0.0800\), so:
The strict-group crude difference is \(+1.00\) percentage point. The arithmetic is consistent with the nested data: the broad group contains 100 additional people in each strategy, with 4 additional outcomes in the treated strategy and 28 in the comparison strategy. These are unadjusted observed contrasts, not causal effects. The change may reflect the different people included, as well as differences in treatment assignment and confounding. The sensitivity analysis should report the population change rather than describe the result as a mere change in coding.
Worked Alternatives for Exposure, Outcome, and Follow-Up
Worked Example: Alternative Evidence of Treatment Initiation
Hypothetical data. Suppose the primary exposure rule classifies treatment using a pharmacy dispensing record. Among 600 eligible people, 220 have such a record and 26 have an outcome; the other 380 are classified in the comparison strategy, with 57 outcomes. A defensible alternative also accepts a documented administration record when no dispensing record is present. There are 40 such additional initiators, 8 with outcomes. Under this alternative, those 40 are moved out of the comparison group. Calculate the crude risk differences under each rule.
With the primary rule, the risks are \(26/220=0.1182\) and \(57/380=0.1500\), giving:
The observed difference is \(-3.18\) percentage points. With the alternative rule, the exposed group has \(220+40=260\) people and \(26+8=34\) outcomes. The comparison group has \(380-40=340\) people and \(57-8=49\) outcomes. Therefore:
The alternative-rule observed difference is \(-1.33\) percentage points. The calculation checks the reclassification explicitly: the 40 newly classified initiators and their 8 outcomes are removed from the comparison group and added to the exposed group. This scenario is useful only if the records identify administrations and the protocol defines why they count as initiation. The crude contrast is not a causal treatment effect, and the two exposure rules may represent different treatment strategies.
Worked Example: Outcome Definition and Follow-Up Horizon
Hypothetical data. In two strategy groups of 200 people each, 20 and 30 people, respectively, experience hospitalization by day 30. A broader outcome includes hospitalization or emergency care; it adds 12 events in the first group and 15 in the second, with no person counted twice. By day 90, the hospitalization outcome has occurred in 36 and 48 people. Calculate the observed risk differences for the primary outcome by day 30, the broader outcome by day 30, and the primary outcome by day 90.
For hospitalization by day 30, the risks are \(20/200=0.1000\) and \(30/200=0.1500\). The risk difference is \(0.1000-0.1500=-0.0500\), or \(-5.00\) percentage points.
For the broader day-30 outcome, the counts are \(20+12=32\) and \(30+15=45\). Its risks are \(32/200=0.1600\) and \(45/200=0.2250\), giving a risk difference of \(0.1600-0.2250=-0.0650\), or \(-6.50\) percentage points.
For hospitalization by day 90, the risks are \(36/200=0.1800\) and \(48/200=0.2400\). The risk difference is \(0.1800-0.2400=-0.0600\), or \(-6.00\) percentage points. These comparisons differ in what counts as an event or when it can occur. A larger absolute difference under one definition does not establish that it is more valid. The protocol must justify the clinical outcome and time horizon; interpretation should name both.
Diagnostics, Reporting, and Common Pitfalls
Useful diagnostics begin with implementation checks. For each scenario, report the number eligible, the number assigned to each strategy, the number with observed outcomes, and the amount of follow-up available. For nested eligibility rules, verify that the stricter group is contained in the broader group. For reclassified exposure, account for every person moved between groups. For outcome alternatives, check overlap and avoid double counting. For follow-up alternatives, confirm that event ascertainment and censoring rules are defined consistently at each horizon.
Large shifts in group size, outcome frequency, or follow-up should trigger investigation of data extraction and rule implementation as well as substantive interpretation. If an alternative excludes many people because a required field is missing, the difference may reflect data availability rather than the intended clinical definition. If a scenario cannot be applied to a meaningful portion of the cohort, report that limitation rather than treating the result as a clean comparison.
A strong report states the primary rule, gives the rationale for each alternative, shows the corresponding cohort and outcome summaries, and interprets each estimate as belonging to its own operationalized question. Prespecification should include which scenarios will be run and how they will be compared. If several definitions are uncertain, a small, scientifically motivated set is often more interpretable than every possible combination. Joint scenarios are warranted when two ambiguities plausibly interact, but their implications should be described separately.
- Do not select definitions by result. Choosing the outcome rule that yields the largest apparent benefit turns a sensitivity analysis into outcome-driven analysis.
- Do not call every difference a failure of robustness. An eligibility change can alter the target population; a follow-up change can alter the estimand.
- Do not infer causal validity from stability. Similar estimates across definitions do not rule out confounding, selection bias, measurement error, or violations of other causal assumptions.
- Do not confuse protocol sensitivity with a correction for bias. These comparisons expose dependence on operational choices; they do not by themselves correct misclassification or quantify unmeasured bias.
The main alternatives serve different purposes. A single primary protocol offers a focused answer to one prespecified question but may hide dependence on ambiguous records. A protocol sensitivity analysis shows how specified operational alternatives change the emulation. Quantitative bias analysis instead requires assumptions about a bias mechanism and quantifies its possible impact; it is not a substitute for defining the trial. When a definition is not genuinely ambiguous, repeatedly varying it can obscure the primary question rather than strengthen the analysis.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- A stricter eligibility rule keeps a subset of the primary cohort. What two quantities should be checked before interpreting a changed risk difference?
- Under the primary exposure rule, 30 of 300 people in one strategy group and 45 of 300 in the other have an outcome. An alternative rule moves 20 people, including 4 with outcomes, from the second group to the first. Calculate the alternative crude risk difference, first group minus second group.
- Why is a 90-day outcome analysis not simply a repeat of a 30-day outcome analysis with more observations?
- What is wrong with choosing among outcome definitions after identifying which one produces the largest apparent treatment benefit?
- Does a similar estimate under several eligibility definitions establish that confounding is absent? Explain.
Solutions. (1) Check that the strict group is actually nested within the primary group and report how the numbers eligible and their outcome risks change. Also inspect whether changes in treatment-group composition could account for the contrast change. (2) The alternative first group has \(320\) people and \(34\) outcomes; the second has \(280\) people and \(41\) outcomes. The difference is \(34/320-41/280=0.1063-0.1464=-0.0402\), or about \(-4.02\) percentage points. This is a crude observed contrast. (3) The horizon changes which events can count, so the outcome is \(Y^a(90)\) rather than \(Y^a(30)\); the estimand and required follow-up information differ. (4) It makes the choice outcome-driven and undermines the prespecified comparison; definitions should be justified independently of the result. (5) No. Similarity only describes stability to those eligibility alternatives. It does not test or remove confounding or establish other causal assumptions.